Free Trial

Curis (CRIS) Insider Trading & Ownership

Curis logo
$3.70 -0.09 (-2.37%)
(As of 11/20/2024 ET)

Curis (NASDAQ:CRIS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.70%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$17,087.60
Get CRIS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Curis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRIS Insider Buying and Selling by Quarter

Curis Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/31/2022James E DentzerCEOSell154$61.40$9,455.60  
1/27/2022James E DentzerCEOSell120$63.60$7,632.00  
(Data available from 1/1/2013 forward)

CRIS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Curis includes James E Dentzer. Learn more on insiders at CRIS.

5.70% of Curis stock is owned by insiders. Learn more on CRIS's insider holdings.

Curis Key Executives

  • Mr. James E. DentzerMr. James E. Dentzer (Age 57)
    President, CEO, Secretary, Treasurer & Director
    Compensation: $1.07M
  • Ms. Diantha Duvall CPA (Age 52)
    M.B.A., CFO and Principal Financial & Accounting Officer
    Compensation: $719.02k
  • Dr. Jonathan B. Zung Ph.D. (Age 59)
    Chief Development Officer
    Compensation: $691.27k
  • Mr. Mark W. Noel (Age 65)
    Vice President of Technology Management & Intellectual Property
    Compensation: $279.28k
  • Dr. Robert E. Martell M.D. (Age 61)
    Ph.D., Chief Scientific Officer
    Compensation: $537.15k
  • Ms. Elif McDonald
    VP of Investor Relations & Corporate Communications
  • Dr. Reinhard Wilhelm von Roemeling M.D.
    Senior Vice President of Clinical Development


This page (NASDAQ:CRIS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners